Inventor · disambiguated record
Sergio Casimiro Da Silva Leal
Also filed as: DA SILVA LEAL SERGIO CASIMIRO
0 granted patents·4 pending applications·0 citations·filing 2022–2024
Files withREGENERON PHARMA4
Top patents by PatentIndex Score
4 records- 0157US2025025531A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0255US2024024420A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0353US2023295266A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0452US2023302085A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sergio Casimiro Da Silva Leal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →